Marine polysaccharide-based medicine for treating osteoporosis

Abstract

The invention provides a medicine for treating osteoporosis based on marine polysaccharides, which is composed of the following raw materials in parts by weight: 8-10 parts of sea cucumber glycopeptide, 6-8 parts of seaweed polysaccharide, 1.5-2.0 g of glucosamine, fish collagen 6-8 parts of protein peptide, 4-5 parts of Eucommia extract, 3-4 parts of Epimedium extract, 6-8 parts of Caulis Spatholobus extract, 3-4 parts of Rehmannia glutinosa extract, 5-7 parts of Lycium barbarum extract , this formula can eliminate joint inflammation, relieve pain, repair damaged articular cartilage and promote regeneration, and improve immunity by supplementing collagen, polypeptide, polysaccharide, calcium and other nutrients needed by bone joints. TCM theory promotes blood circulation and collaterals, nourishes liver and kidney, strengthens tendons and bones, and together achieves the fundamental purpose of treating osteoporosis.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to a medicine for treating osteoporosis. Background technique [0002] Osteoporosis is a bone and joint disease caused by a variety of reasons. The symptoms are mostly bone pain, limited mobility, shortened body length, hunchback, and easy fractures. Divided into primary and secondary osteoporosis, mostly senile osteoporosis and postmenopausal osteoporosis are the most common, and the elderly and women are the most common groups. With the aggravation of social aging, people suffering from osteoporosis population is also on the rise. [0003] There are two major categories of drugs currently used to treat and prevent the development of osteoporosis. The first category is drugs that inhibit bone resorption, including calcium, vitamin D, calcitonin, bisphosphonates, estrogen and isoflavones; Drugs for promoting bone formation, including fluoride, synthetic steroids, parathyroid hormone, and i...

AI Technical Summary

Problems solved by technology

[0003] There are two major categories of drugs currently used to treat and prevent the development of osteoporosis. The first category is drugs that inhibit bone resorption, including calcium, vitamin D, calcitonin, bisphosphonates, estrogen and isoflavones; Drugs for promoting bone formation, including fluoride, synthetic steroids, parathyroid hormone, and isoflavones. Although these western medicines have certain curative effects, they have large side effects, are expensive, and they need to be taken for a long time. Fundamentally improve the inflammation and lesions of bone and joints, but at the same time fail to treat thoroughly from the cause, so there is an urgent need to develop an effective prescription for the treatment of osteoporosis